News
[Major Debut] Jinlangbo Pharmaceutical Shines at the 2025 China Animal Husbandry Expo
Release time:
2025-05-23
From May 19th to 21st, 2025, the 22nd China Animal Husbandry Expo and the 2025 China International Animal Husbandry Expo were grandly held at the China Railway Qingdao World Expo City. Themed "Showcasing New Business Models, Sharing New Achievements, Enhancing New Impetus, and Leading New Development", this edition of the livestock expo gathered over 1,500 industry leaders from more than 20 countries and regions worldwide. The exhibition covered an indoor and outdoor area of 180,000 square meters, with over 8,000 booths set up. It is expected to attract more than 230,000 professional visitors, making it the largest in scale ever and becoming a significant platform for global animal husbandry exchanges and cooperation.
Jinlangbo Pharmaceutical, deeply aligned with the theme of the exhibition, made a sensational appearance with its 25-hydroxyvitamin D3 full industry chain product, which possesses complete independent intellectual property rights. Leveraging two national invention patent technologies, this product achieves full process autonomy and controllability from raw materials to finished products, boasting significant advantages in bioavailability and stability. At the exhibition, through professional explanations, product displays, and interactive experiences, it comprehensively demonstrated its outstanding performance in enhancing animal health levels and reducing breeding costs.

During the exhibition, the Jinlangbo Pharmaceutical booth was incredibly popular, attracting professional visitors from feed enterprises and breeding groups both domestically and internationally. Many industry experts and customers spoke highly of the product's innovativeness and practicality, expressing their eagerness for deeper cooperation. A technical director from a large breeding enterprise said, "The effect of 25-hydroxyvitamin D3 in improving animal bone development and enhancing immunity is impressive. It is an innovative product that we urgently need in our transformation and upgrading process.". "
![]() |
![]() |

Jinlangbo Pharmaceutical has always adhered to the development philosophy of "quality first" and established a strict quality control system in the research, development, and production of 25-hydroxyvitamin D3 products. The company's sales team stated that through this exhibition, they not only gained cooperation intentions from numerous potential customers but also enhanced their confidence in market expansion. In the future, Jinlangbo Pharmaceutical will continue to increase R&D investment, optimize product performance, and provide global customers with higher quality and more efficient animal nutrition solutions.

More news

